The largest database of trusted experimental protocols

5 protocols using kreapure columns

1

Comparative Genomic Hybridization of FFPE DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Genome CGH Microarray 244A slides (Agilent Technologies, CA, USA) were used for FFPE extracted DNA samples. We followed the protocol described in [30 (link), 31 (link)]. A total of 2.5 μg sex matched control DNA (Promega, WI, USA) was fragmented by sonication. The FFPE DNA was fragmented only if there was any large molecular weight DNA. About 500 ng of the fragmented samples were then run on 1.5% agarose gel for 1 hour to check the extent of fragmentation of the DNA. Once fragmentation was deemed appropriate, 2 μg of the control DNA was labeled with Cy3 (Agilent technologies, CA, USA) and 2μg of FFPE DNA with Cy5 (Agilent technologies, CA, USA) for 30 minutes at 85°C. After labeling the DNA was purified using KREA pure columns (Agilent technologies, CA, USA). The samples were then measured on a Nanodrop and Degree of Labeling (DOL) was calculated according to the following formula;
DegreeofLabeling=(340xpmol/μlofdye)/(ng/lμofGenomicDNAx1000)
The samples were hybridized onto microarray slides only if the DOL was between 1.5–2.5%.
+ Open protocol
+ Expand
2

Comprehensive Genomic DNA Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA (500 ng) from the same batch of tumour DNA as used in methylation profiling was analysed using the Agilent oligonucleotide array-bases CGH (4x microarray) following the manufacturer’s instructions (Agilent Technologies, Santa Clara, CA). In brief, genomic DNA of samples and female reference DNA (a normal control DNA) (Promega, Madison, WI) were first fragmented for 30 s at 95 °C and 30 min at 95 °C respectively, and then the reference and sample DNA were labeled with ULS-Cy3 and ULS-Cy5 dye with the ratio 1 μL per 1 μg DNA, respectively. The non-reacted Cy-ULS dyes were removed using Agilent KREApure columns to reduce possible background noise for array screening. Optimal Cy5 degree of labeling (range between 0.75 % and 2.5 %) with a Cy3 minus Cy5 range between 1 % and 2 % were used as a quality control guideline for sample labeling before hybridizing to the array. Samples and references DNA were hybridized on to the microarray at 65 °C for 40 h, and then washed and scanned. aCGH result analyses was performed using the Partek® Genomics Suite™ version 6.03 (Partek Inc., St. Louis, MO).
+ Open protocol
+ Expand
3

FFPE Tumor DNA Microarray Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA extraction was performed using the QIAamp DNA micro kit (Qiagen #56304, Hilden, Germany) on macro-dissected FFPE tumor blocks. Fragmentation and labeling were done according to manufacturer's protocol (Agilent Technologies, Courtaboeuf, France), using 1.5 μg of genomic DNA. Tumor DNA was labeled in Cy5, and a female reference DNA (Promega #G1521, Madison, USA) was labeled in Cy3. Labeled samples were then purified using KREApure columns (Agilent Technologies #5190-0418). Labeling efficiency was calculated using a Nanodrop ND2000 Spectrophotometer. Cohybridization was performed on custom oligonucleotide arrays (Agilent Technologies #G4125A). These arrays are densified for some cancer genes loci, based on the 4 × 180K Agilent SurePrint G3 Human whole-genome design. Slides were washed, dried, and scanned on the Agilent SureScan microarray scanner. Scanned images were processed using the Agilent Feature Extraction software V11.5 and the analysis was carried out using the Agilent Genomic Workbench software V7.0.
+ Open protocol
+ Expand
4

Comparative Genomic Hybridization of Tumor DNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four hundred nanograms of tumor DNA and normal prostate DNA were labeled with Cy5 and Cy3 dyes, respectively, following the Genomic DNA Universal Linkage System labeling kit protocol (Agilent; Santa Clara, CA). Excess fluors were removed via Agilent Kreapure columns. Following the protocol for Agilent Array-Based CGH for Genomic DNA Analysis, the labeled probes were blocked and hybridized to the microarrays for 40 hours at 65°C while rotating at 20 rpm, utilizing COT1 as competitor DNA. Arrays were washed and scanned using an Agilent SureScan microarray reader at 3μm resolution and data was retrieved using Agilent’s Feature Extraction Software. Quality control (QC) measurements were assessed based on array scans. Samples that did not meet the QC value of 1.00 in the Good Grid category indicating an issue with control probes were excluded from analysis. After QC eliminations, the copy number of 17 NED outcome and 17 MET outcome tumor DNAs were analyzed using Agilent Cytogenomics Software.
+ Open protocol
+ Expand
5

Genomic DNA Extraction and Microarray Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNA extraction was performed by macrodissecting FFPE tumor blocks followed by the use of the QIAamp DNA micro kit (Qiagen #56304, Hilden, De). Fragmentation and labeling were carried out according to the manufacturer's protocol (Agilent Technologies), using 1.5 µg of genomic DNA. Tumor DNA was labeled in Cy5, and a reference DNA with male or female sex-mismatch (Promega #G1471 and #G1521, Madison, USA) was labeled in Cy3. The labeled samples were then purified using KREApure columns (Agilent Technologies #5190-0418). The labeling efficiency was calculated using a Nanodrop ND2000 spectrophotometer. Cohybridization was performed on the 4 × 180K Agilent SurePrint G3 Human whole-genome design (Agilent Technologies # G4449A). The slides were washed, dried and scanned on the Agilent SureScan microarray scanner. The scan images were processed using Agilent Feature Extraction software V11.5 and the analysis was carried out using Agilent Genomic Workbench software V7.0.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!